Position in LLY
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$6,292,210
+$1,639,094 QoQ
Shares Held
5,246
+3.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#1,546
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. LLY ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,703 | $9,829,400 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
5,246 | $6,292,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,611 | $3,805,013 | |
| 4 | PFE |
Pfizer Inc
|
152,066 | $3,661,749 | |
| 5 | ABBV |
AbbVie Inc.
|
12,987 | $3,268,048 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,344 | $2,439,861 | |
| 7 | AMGN |
Amgen Inc
|
6,083 | $2,202,775 | |
| 8 | AZN |
Astrazeneca PLC
|
10,283 | $1,949,862 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,292,210 | 5,246 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $4,653,116 | 5,059 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,221,870 | 4,859 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $3,611,279 | 4,733 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,650,538 | 4,683 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $4,004,837 | 4,849 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,328,092 | 4,311 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,860,040 | 4,357 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $3,826,135 | 4,226 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,090,057 | 3,972 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,350,916 | 4,033 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,883,177 | 3,506 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,707,087 | 3,640 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $1,303,622 | 3,796 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,203,613 | 3,290 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,078,695 | 3,336 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,166,255 | 3,597 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $990,553 | 3,459 | Shares | Sole | 2022-06-03 | |
| 2021-12-31 | $931,413 | 3,372 | Shares | Sole | 2022-03-02 | |
| 2021-09-30 | $793,656 | 3,435 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $839,813 | 3,659 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $705,619 | 3,777 | Shares | Sole | 2021-05-26 | |
| 2020-12-31 | $653,241 | 3,869 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $690,365 | 4,664 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $754,735 | 4,597 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $637,557 | 4,596 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||